EventHealthBusiness
5 days ago
Owkin and Sanofi expand AI collaboration for drug development agents
The multi-year agreement will co-develop AI-enabled biopharma agents for drug R&D. Owkin will lead development of AI agents purpose-built for Sanofi's research pipeline.
·
5 days ago